Simpa S. Salami, MD, MPH

Assistant Professor of Urology
University of Michigan

Dr. Salami is a fellowship-trained, board-certified Urologic Oncologist and Assistant Professor of Urology at the University of Michigan. He obtained his MD from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he graduated from the Master of Public Health program at Harvard University. He subsequently pursued his General Surgery internship at Brigham and Women’s Hospital in Boston, Urology residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology fellowship at the University of Michigan in Ann Arbor. Dr. Salami’s research interests are in early detection and staging of prostate and kidney cancer. He seeks to leverage novel imaging, machine learning, and next generation sequencing approaches to characterize cancer heterogeneity and tumor multifocality. The goal of his research is to develop novel cancer biomarkers and elucidate optimal paradigms for early detection of cancer, risk stratification, prognostication and prediction of treatment response.

Disclosure information not submitted.

Presentation(s):

• PD01-10: Whole Transcriptome Sequencing of Clear Cell Renal Cell Carcinoma Reveals a Multigene Expression Prognostic Signature

  Friday, May 13, 2022
  8:30 AM – 8:40 AM